Quick Answer
Edwards Lifesciences Corp reported Operating Income of $1.26 billion for fiscal year 2025.
Edwards Lifesciences Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $1.26B | -8.3% |
| 2024 | $1.38B | +5.3% |
| 2023 | $1.31B | -12.6% |
| 2022 | $1.50B | -11.4% |
| 2021 | $1.69B | +88.3% |
| 2020 | $897.60M | -21.7% |
| 2019 | $1.15B | +53.3% |
| 2018 | $748.20M | -31.3% |
| 2017 | $1.09B | +45.0% |
| 2016 | $751.20M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $307.10M | -12.4% | -25.3% |
| June 30, 2025 | $411.20M | +12.2% | +4.2% |
| March 31, 2025 | $394.80M | +13.1% | +12.6% |
| September 30, 2024 | $350.60M | -4.2% | -4.3% |
| June 30, 2024 | $366.50M | +39.1% | +5.0% |
| March 31, 2024 | $349.00M | -10.1% | -4.6% |
| September 30, 2023 | $365.90M | -9.1% | +38.9% |
| June 30, 2023 | $263.50M | -42.7% | -32.2% |
- Edwards Lifesciences Corp showed a decrease of -8.3% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Edwards Lifesciences Corp’s operating income has grown by 68.3% (from $751.20 million to $1.26 billion).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: